Cagri-Sema Blend (5 mg, 5 mg)

Cagrilintide (5mg) / Semaglutide (5mg) Research Blend This research-grade peptide combination contains multiple active compounds in lyophilized form, manufactured to pharmaceutical standards for laboratory investigation. Blend Components: - Cagrilintide: 5mg (long-acting amylin analog) - Semaglutide: 5mg (GLP-1 receptor agonist) Research Applications: This dual peptide research blend is utilized in scientific studies examining: - Amylin and GLP-1 receptor co-activation mechanisms - Synergistic pathway signaling studies - Dual receptor interaction research - Comparative blend efficacy analysis - In-vitro combination pharmacology studies Product Specifications: - Blend Type: Dual Peptide Research Blend - Form: Lyophilized powder - Purity: ≥98% (HPLC verified) - Storage: Refrigerated (2-8°C) - Supplied with: Certificate of Analysis Laboratory Use Only: This product is manufactured and distributed exclusively for in-vitro research purposes. It is NOT approved for human consumption, clinical applications, or therapeutic use. Intended for qualified researchers and licensed laboratory facilities only. Handling Requirements: Reconstitution and handling must be performed in controlled laboratory environments following standard research protocols. Refer to technical documentation for proper storage and preparation guidelines. Regulatory Compliance: By purchasing this research compound, buyer confirms understanding that this product is sold strictly for laboratory research and agrees to comply with all applicable regulations governing research materials.